ZEISS Medical Technology has announced that, the Food and Drug Administration (FDA) of the United States has approved the QUATERA 700, which has been arevolution in the phaco technology. The approval is also including the ZEISS patented QUATTRO Pump, which has been delivering an exceptional level of the chamber stability independent of the intra-ocular pressure (IOP) and also the flow.
SRI Ganesh, Managing Director and Chairman of Nethradhama Super Speciality Eye Hospital, Bangalore (India) said that, what excites him the most regarding the QUATERA 700 has been the QUATTRO synchronized fluid system of pump and how he can have both the highest levels of the efficiency along with maintaining an extremely stable chamber, along with an independent of IOP.
The ZEISS QUATERA 700 has been designed for increasing a workflow efficiency of the surgeon from the clinic to the operating room (OR), along with enabling one of the digitally integrated surgical workflow. It is working as a single sterile or dashboard integrating patient data from the several other systems and the view of microscope, which is available in the real-time for the operating room staff.
Elizabeth Yeu, managing director of the Virginia Eye Consultants in Virginia (USA) said, it has been great for seeing that ZEISS has also added another critical piece to the cataract workflow, which is a digital solution that is further enabling them for becoming more efficient and effective during the procedures of surgery.
